A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Efficacy and Safety of Intralesional Bleomycin for Treatment of Lymphangioma: Report from a Tertiary Care Hospital of Bihar
2022
International journal of pharmaceutical sciences review and research
Lymphangioma is a benign tumor of lymphatic vessels, with 75% cases occurring in head and neck. Surgical excision is the traditional management. Intralesional sclerotherapy has become a method of treatment for lymphangiomas in children. A retrospective clinical trial was conducted to evaluate the efficacy of intralesional bleomycin sclerotherapy (IBS) in the treatment of lymphangiomas in children. Methodology: A prospective study was conducted by the Department of General Surgery of MGM Medical
doi:10.47583/ijpsrr.2022.v77i01.001
fatcat:cqbfw2qfgzdtfayjbg4dgn246i